By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Coherus Biosciences 

201 Redwood Shores Parkway
Suite 200
Redwood City  California  94065  U.S.A.
Phone: 800-794-5434 Fax: n/a



Company News
Coherus Biosciences Reports Third Quarter 2014 Financial And Operating Results 12/16/2014 7:59:17 AM
Coherus Biosciences To Present At The J.P. Morgan Healthcare Conference On January 12 12/8/2014 8:43:08 AM
Coherus Biosciences To Host Earnings Conference Call On December 15 12/5/2014 11:53:34 AM
Coherus Biosciences Announces Closing Of Initial Public Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 11/13/2014 7:34:08 AM
Coherus Biosciences Prices Initial Public Offering Of $85 Million Of Common Stock 11/6/2014 10:33:52 AM
Bay Area's Coherus Biosciences Sets Terms For $85 Million IPO 10/27/2014 6:05:52 AM
Bay Area Biosimilar Firm Coherus Biosciences Eyes $86.25 Million IPO 9/26/2014 6:18:37 AM
Coherus Biosciences Appoints Mary Szela To Board of Directors 9/25/2014 8:03:41 AM
Coherus Biosciences' Biosimilar Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study 8/15/2014 6:34:54 AM
Coherus Biosciences Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy) 7/16/2014 9:32:29 AM